↓ Skip to main content

Dove Medical Press

Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed…

Overview of attention for article published in Cancer Management and Research, November 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Readers on

mendeley
3 Mendeley
Title
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program
Published in
Cancer Management and Research, November 2023
DOI 10.2147/cmar.s423970
Pubmed ID
Authors

Pietro Quaglino, Paolo A Ascierto, Francesca Consoli, Paola Queirolo, Francesco Spagnolo, Maria Francesca Morelli, Rossana Berardi, Vanna Chiarion-Sileni, Marco Tucci, Teresa Troiani, Barbara Melotti, Ernesto Rossi, Mario Mandala, Gaetana Rinaldi, Ilaria Gioia Marcon, Matteo Pizzuti, Michele Del Vecchio

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 67%
Other 1 33%
Readers by discipline Count As %
Unspecified 2 67%
Nursing and Health Professions 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2024.
All research outputs
#21,377,270
of 26,238,332 outputs
Outputs from Cancer Management and Research
#1,149
of 2,100 outputs
Outputs of similar age
#265,243
of 372,406 outputs
Outputs of similar age from Cancer Management and Research
#5
of 14 outputs
Altmetric has tracked 26,238,332 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,100 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 372,406 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.